| Bunyaviridae: the viruses and their replication. CS Schmaljohn, JW Hooper | 559 | 2001 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 508 | 2016 |
| A recombinant vesicular stomatitis virus Ebola vaccine JA Regules, JH Beigel, KM Paolino, J Voell, AR Castellano, Z Hu, ... New England Journal of Medicine 376 (4), 330-341, 2017 | 448 | 2017 |
| Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus Y Edghill-Smith, H Golding, J Manischewitz, LR King, D Scott, M Bray, ... Nature medicine 11 (7), 740-747, 2005 | 425 | 2005 |
| Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox JW Hooper, E Thompson, C Wilhelmsen, M Zimmerman, MA Ichou, ... Journal of virology 78 (9), 4433-4443, 2004 | 324 | 2004 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 319 | 2015 |
| A lethal disease model for hantavirus pulmonary syndrome JW Hooper, T Larsen, DM Custer, CS Schmaljohn Virology 289 (1), 6-14, 2001 | 314 | 2001 |
| Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates JW Hooper, DM Custer, E Thompson Virology 306 (1), 181-195, 2003 | 261 | 2003 |
| DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge JW Hooper, DM Custer, CS Schmaljohn, AL Schmaljohn Virology 266 (2), 329-339, 2000 | 213 | 2000 |
| Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine DM Custer, E Thompson, CS Schmaljohn, TG Ksiazek, JW Hooper Journal of virology 77 (18), 9894-9905, 2003 | 199 | 2003 |
| DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection JW Hooper, KI Kamrud, F Elgh, D Custer, CS Schmaljohn Virology 255 (2), 269-278, 1999 | 195 | 1999 |
| Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease JW Golden, CR Cline, X Zeng, AR Garrison, BD Carey, EM Mucker, ... JCI insight 5 (19), 2020 | 194 | 2020 |
| DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys JW Hooper, DM Custer, E Thompson, CS Schmaljohn Journal of virology 75 (18), 8469-8477, 2001 | 190 | 2001 |
| Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus K Spik, A Shurtleff, AK McElroy, MC Guttieri, JW Hooper, C Schmaljohn Vaccine 24 (21), 4657-4666, 2006 | 188 | 2006 |
| Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge JW Hooper, JW Golden, AM Ferro, AD King Vaccine 25 (10), 1814-1823, 2007 | 185 | 2007 |
| Treatment of hantavirus pulmonary syndrome CB Jonsson, J Hooper, G Mertz Antiviral research 78 (1), 162-169, 2008 | 184 | 2008 |
| Subunit recombinant vaccine protects against monkeypox JM Heraud, Y Edghill-Smith, V Ayala, I Kalisz, J Parrino, ... The Journal of Immunology 177 (4), 2552-2564, 2006 | 177 | 2006 |
| Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice KL Bengtsson, H Song, L Stertman, Y Liu, DC Flyer, MJ Massare, RH Xu, ... Vaccine 34 (16), 1927-1935, 2016 | 127 | 2016 |
| Reovirus M2 gene is associated with chromium release from mouse L cells P Lucia-Jandris, JW Hooper, BN Fields Journal of virology 67 (9), 5339-5345, 1993 | 127 | 1993 |
| Rescue of Hantaan virus minigenomes K Flick, JW Hooper, CS Schmaljohn, RF Pettersson, H Feldmann, R Flick Virology 306 (2), 219-224, 2003 | 122 | 2003 |
Chris A. Whitehouse, Ph.D.Deputy Director, Office of Research, FDA在 fda.hhs.gov 的电子邮件经过验证
